# Immunology Sector

Canonical URL: https://biopharmsignal.com/sector/immunology

Immunology includes companies working on autoimmune disease, inflammation, allergy, and immune-modulating therapies. This sector page brings together names focused on controlling overactive immune pathways or restoring immune balance across chronic inflammatory disorders.

Companies currently grouped under Immunology: 95

## Recent Sector News

- 2026-10-07 20:05 EST — ALEC — [Alector to Host Virtual Research and Development Event Highlighting Wholly Owned Alector Brain Carrier (ABC)- Enabled Pipeline](https://biopharmsignal.com/news/ALEC/alector-to-host-virtual-research-and-development-event-highlighting-wholly-owned-b8046d79) — Source: Alector
- 2026-10-07 12:00 EST — KYTX — [Kyverna Therapeutics to Present Positive Data in Stiff Person Syndrome and Progressive Multiple Sclerosis at MSToronto2026](https://biopharmsignal.com/news/KYTX/kyverna-therapeutics-to-present-positive-data-in-stiff-person-syndrome-and-progr-0d80e7c7) — Source: Kyverna Therapeutics
- 2026-10-07 05:00 EST — NRIX — [Nurix Therapeutics Announces First Patient Enrolled in Phase 1b/2 Combination Study of Bexobrutideg in Chronic Lymphocytic Leukemia](https://biopharmsignal.com/news/NRIX/nurix-therapeutics-announces-first-patient-enrolled-in-phase-1b-2-combination-st-06e28a5d) — Source: Nurix Therapeutics
- 2026-10-06 20:05 EST — EQ — [Equillium Announces Poster Presentation at the 50th Anniversary La Jolla Immunology Conference](https://biopharmsignal.com/news/EQ/equillium-announces-poster-presentation-at-the-50th-anniversary-la-jolla-immunol-4c232416) — Source: Equillium, Inc.
- 2026-10-06 13:00 EST — INMB — [INmune Bio to Attend the 2026 Maxim Growth Summit](https://biopharmsignal.com/news/INMB/inmune-bio-to-attend-the-2026-maxim-growth-summit-fd83392c) — Source: INmune Bio
- 2026-10-06 11:00 EST — REGN — [Regeneron Showcases Advances in Care Across Several Cancers and Cancer-associated Complications at ESMO 2026](https://biopharmsignal.com/news/REGN/regeneron-showcases-advances-in-care-across-several-cancers-and-cancer-associate-e8a57290) — Source: Regeneron Pharmaceuticals
- 2026-10-06 00:13 EST — SYRE — [Spyre Therapeutics Announces Pricing of $350.0 Million Public Offering of Common Stock](https://biopharmsignal.com/news/SYRE/spyre-therapeutics-announces-pricing-of-350-0-million-public-offering-of-common--53577d04) — Source: Spyre Therapeutics, Inc.
- 2026-10-05 20:05 EST — ELDN — [Eledon Pharmaceuticals Announces Presentation at the American Society of Nephrology Kidney Week 2026 Annual Meeting](https://biopharmsignal.com/news/ELDN/eledon-pharmaceuticals-announces-presentation-at-the-american-society-of-nephrol-88fdd2b5) — Source: Eledon Pharmaceuticals, Inc.
- 2026-10-05 20:05 EST — EQ — [Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504](https://biopharmsignal.com/news/EQ/equillium-receives-australian-regulatory-clearance-to-initiate-first-in-human-cl-68afdbf7) — Source: Equillium, Inc.
- 2026-10-05 20:01 EST — CABA — [Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/CABA/cabaletta-bio-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4-edb737a6) — Source: Cabaletta Bio
- 2026-10-05 20:01 EST — SYRE — [Spyre Therapeutics Announces Proposed Public Offering of its Common Stock](https://biopharmsignal.com/news/SYRE/spyre-therapeutics-announces-proposed-public-offering-of-its-common-stock-34915569) — Source: Spyre Therapeutics, Inc.
- 2026-10-05 11:00 EST — NRIX — [Nurix Therapeutics Announces Second Research Term Extension for Oncology Program Under Collaboration with Gilead Sciences](https://biopharmsignal.com/news/NRIX/nurix-therapeutics-announces-second-research-term-extension-for-oncology-program-a14e7f92) — Source: Nurix Therapeutics
- 2026-10-05 11:00 EST — ALEC — [Alector Enters Global License Agreement with Genentech for Brain Penetrant GCase Enzyme Replacement Therapy for Parkinson’s Disease and Other Neurodegenerative Diseases](https://biopharmsignal.com/news/ALEC/alector-enters-global-license-agreement-with-genentech-for-brain-penetrant-gcase-e4a24c18) — Source: Alector
- 2026-10-02 20:05 EST — VERA — [Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/VERA/vera-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4-aef4d701) — Source: Vera Therapeutics
- 2026-10-02 20:05 EST — SYRE — [Spyre Therapeutics Announces Grants of Inducement Awards](https://biopharmsignal.com/news/SYRE/spyre-therapeutics-announces-grants-of-inducement-awards-88577a32) — Source: Spyre Therapeutics, Inc.
- 2026-10-02 13:24 EST — VERA — [Vera Therapeutics Announces ORIGIN 3 Final Efficacy Analysis of TRUTAKNA™ (atacicept-vymj) in IgA Nephropathy Will be A Featured Late-breaking Oral Presentation at the Opening Plenary Session of ASN Kidney Week 2026](https://biopharmsignal.com/news/VERA/vera-therapeutics-announces-origin-3-final-efficacy-analysis-of-trutakna-atacice-a746bd05) — Source: Vera Therapeutics
- 2026-10-02 11:30 EST — IFRX — [InflaRx to Present Late-Breaking Pre-clinical Data on Izicopan at Kidney Week 2026](https://biopharmsignal.com/news/IFRX/inflarx-to-present-late-breaking-pre-clinical-data-on-izicopan-at-kidney-week-20-87449a4c) — Source: Inflarx NV
- 2026-10-02 11:00 EST — RNAC — [Cartesian Therapeutics Announces New Employment Inducement Grants](https://biopharmsignal.com/news/RNAC/cartesian-therapeutics-announces-new-employment-inducement-grants-90a5e585) — Source: Cartesian Therapeutics
- 2026-10-01 20:30 EST — XFOR — [X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/XFOR/x4-pharmaceuticals-announces-inducement-grants-under-nasdaq-listing-rule-5635-c--356c74ce) — Source: X4 Pharmaceuticals
- 2026-10-01 15:35 EST — REGN — [Ubamatamab (MUC16xCD3) Shows a High Rate of Durable Responses in Initial Study of Patients with Advanced Low-Grade Serous Ovarian Cancer (LGSOC)](https://biopharmsignal.com/news/REGN/ubamatamab-muc16xcd3-shows-a-high-rate-of-durable-responses-in-initial-study-of--ec0faf40) — Source: Regeneron Pharmaceuticals

## Companies

- [ABBV](https://biopharmsignal.com/company/ABBV) — AbbVie Inc
- [SLRN](https://biopharmsignal.com/company/SLRN) — ACELYRIN, INC.
- [ACHL](https://biopharmsignal.com/company/ACHL) — Achilles Therapeutics
- [ACRS](https://biopharmsignal.com/company/ACRS) — Aclaris Therapeutics
- [ALDX](https://biopharmsignal.com/company/ALDX) — Aldeyra Therapeutics, Inc.
- [ALEC](https://biopharmsignal.com/company/ALEC) — Alector
- [ALLK](https://biopharmsignal.com/company/ALLK) — Allakos
- [ALPN](https://biopharmsignal.com/company/ALPN) — Alpine Immune Sciences
- [ANAB](https://biopharmsignal.com/company/ANAB) — AnaptysBio, Inc.
- [APLS](https://biopharmsignal.com/company/APLS) — Apellis Pharmaceuticals
- [APGE](https://biopharmsignal.com/company/APGE) — Apogee Therapeutics
- [ARGX](https://biopharmsignal.com/company/ARGX) — Argenx
- [ARGS](https://biopharmsignal.com/company/ARGS) — Argos
- [ASLN](https://biopharmsignal.com/company/ASLN) — ASLAN Pharmaceuticals
- [ATRA](https://biopharmsignal.com/company/ATRA) — Atara Biotherapeutics, Inc.
- [ATYR](https://biopharmsignal.com/company/ATYR) — aTyr Pharma
- [AUPH](https://biopharmsignal.com/company/AUPH) — Aurinia Pharmaceuticals Inc
- [AVTX](https://biopharmsignal.com/company/AVTX) — Avalo Therapeutics
- [BHVN](https://biopharmsignal.com/company/BHVN) — Biohaven
- [BNTX](https://biopharmsignal.com/company/BNTX) — BioNTech
- [BMY](https://biopharmsignal.com/company/BMY) — BMYBristol-Myers Squibb Company
- [CABA](https://biopharmsignal.com/company/CABA) — Cabaletta Bio
- [CALC](https://biopharmsignal.com/company/CALC) — CalciMedica
- [CRDL](https://biopharmsignal.com/company/CRDL) — Cardiol Therapeutics Inc
- [RNAC](https://biopharmsignal.com/company/RNAC) — Cartesian Therapeutics
- [CLDX](https://biopharmsignal.com/company/CLDX) — Celldex Therapeutics
- [CMMB](https://biopharmsignal.com/company/CMMB) — Chemomab Therapeutics
- [CNTB](https://biopharmsignal.com/company/CNTB) — Connect Biopharma Holdings Limited
- [CUE](https://biopharmsignal.com/company/CUE) — Cue Biopharma Inc
- [ELDN](https://biopharmsignal.com/company/ELDN) — Eledon Pharmaceuticals, Inc.
- [LLY](https://biopharmsignal.com/company/LLY) — Eli Lilly
- [ENTA](https://biopharmsignal.com/company/ENTA) — Enanta Pharmaceuticals
- [EQ](https://biopharmsignal.com/company/EQ) — Equillium, Inc.
- [EVAX](https://biopharmsignal.com/company/EVAX) — Evaxion Biotech
- [XGN](https://biopharmsignal.com/company/XGN) — Exagen
- [FWBI](https://biopharmsignal.com/company/FWBI) — First Wave BioPharma
- [FBRX](https://biopharmsignal.com/company/FBRX) — Forte Biosciences
- [FRTX](https://biopharmsignal.com/company/FRTX) — Fresh Tracks Therapeutics
- [GLPG](https://biopharmsignal.com/company/GLPG) — Galapagos NV
- [GOSS](https://biopharmsignal.com/company/GOSS) — Gossamer Bio
- [GRI](https://biopharmsignal.com/company/GRI) — GRI Bio
- [GYRE](https://biopharmsignal.com/company/GYRE) — Gyre Therapeutics
- [HCWB](https://biopharmsignal.com/company/HCWB) — HCW Biologics
- [HCM](https://biopharmsignal.com/company/HCM) — HUTCHMED
- [IMAB](https://biopharmsignal.com/company/IMAB) — I-MABDR
- [IDRA](https://biopharmsignal.com/company/IDRA) — Idera
- [IMUX](https://biopharmsignal.com/company/IMUX) — Immunic
- [IMVT](https://biopharmsignal.com/company/IMVT) — Immunovant
- [IMMP](https://biopharmsignal.com/company/IMMP) — Immutep Limited
- [INCY](https://biopharmsignal.com/company/INCY) — Incyte
- [IFRX](https://biopharmsignal.com/company/IFRX) — Inflarx NV
- [INMB](https://biopharmsignal.com/company/INMB) — INmune Bio
- [KZR](https://biopharmsignal.com/company/KZR) — Kezar Life Sciences
- [KA](https://biopharmsignal.com/company/KA) — Kineta
- [KNSA](https://biopharmsignal.com/company/KNSA) — Kiniksa
- [KYMR](https://biopharmsignal.com/company/KYMR) — Kymera
- [KYTX](https://biopharmsignal.com/company/KYTX) — Kyverna Therapeutics
- [LABP](https://biopharmsignal.com/company/LABP) — Landos Biopharma
- [MREO](https://biopharmsignal.com/company/MREO) — Mereo BioPharma
- [MACK](https://biopharmsignal.com/company/MACK) — Merrimack
- [MRUS](https://biopharmsignal.com/company/MRUS) — Merus
- [MRNA](https://biopharmsignal.com/company/MRNA) — Moderna, Inc.
- [MLTX](https://biopharmsignal.com/company/MLTX) — MoonLake Immunotherapeutics
- [MOR](https://biopharmsignal.com/company/MOR) — MorphoSys
- [MYMD](https://biopharmsignal.com/company/MYMD) — MyMD Pharmaceuticals
- [NKTR](https://biopharmsignal.com/company/NKTR) — Nektar Therapeutics
- [NVS](https://biopharmsignal.com/company/NVS) — Novartis AG
- [NRIX](https://biopharmsignal.com/company/NRIX) — Nurix Therapeutics
- [OCEA](https://biopharmsignal.com/company/OCEA) — Ocean Biomedical
- [OMER](https://biopharmsignal.com/company/OMER) — Omeros
- [PIRS](https://biopharmsignal.com/company/PIRS) — Pieris
- [PTGX](https://biopharmsignal.com/company/PTGX) — Protagonist Therapeutics Inc
- [QTTB](https://biopharmsignal.com/company/QTTB) — Q32 Bio Inc
- [HGEN](https://biopharmsignal.com/company/HGEN) — QHUMANIGEN INCD
- [RAPT](https://biopharmsignal.com/company/RAPT) — RAPT Therapeutics
- [REGN](https://biopharmsignal.com/company/REGN) — Regeneron Pharmaceuticals
- [SABS](https://biopharmsignal.com/company/SABS) — SAB Biotherapeutics
- [SELB](https://biopharmsignal.com/company/SELB) — Selecta
- [STTK](https://biopharmsignal.com/company/STTK) — Shattuck Labs
- [SNGX](https://biopharmsignal.com/company/SNGX) — SOLIGENIX
- [SYRE](https://biopharmsignal.com/company/SYRE) — Spyre Therapeutics, Inc.
- [GPCR](https://biopharmsignal.com/company/GPCR) — Structure Therapeutics
- [THAR](https://biopharmsignal.com/company/THAR) — Tharimmune
- [THRD](https://biopharmsignal.com/company/THRD) — Third Harmonic Bio
- [TLSA](https://biopharmsignal.com/company/TLSA) — Tiziana Life Sciences
- [VCNX](https://biopharmsignal.com/company/VCNX) — Vaccinex
- [VTYX](https://biopharmsignal.com/company/VTYX) — Ventyx Biosciences, Inc.
- [VERA](https://biopharmsignal.com/company/VERA) — Vera Therapeutics
- [VIR](https://biopharmsignal.com/company/VIR) — Vir Biotechnology
- [VRDN](https://biopharmsignal.com/company/VRDN) — Viridian Therapeutics
- [VYNE](https://biopharmsignal.com/company/VYNE) — VYNE Therapeutics Inc.
- [XFOR](https://biopharmsignal.com/company/XFOR) — X4 Pharmaceuticals
- [XNCR](https://biopharmsignal.com/company/XNCR) — Xencor
- [ZLAB](https://biopharmsignal.com/company/ZLAB) — Zai Lab Limited
- [ZURA](https://biopharmsignal.com/company/ZURA) — Zura Bio